サポート ブログ Biointron Receives "Top 100 Chinese Life Science Service Companies of 2023" Award!

Biointron Receives "Top 100 Chinese Life Science Service Companies of 2023" Award!

Biointron 2023-12-09 Read time: 2 mins
Biointron Receives 'Top 100 Chinese Life Science Service Companies of 2023' Award!

The 15th Chinese Healthcare Summit of Entrepreneurs, Scientists, and Investors (CHSESI) was held in Hangzhou, China.

In order to better promote the development of the life sciences sector and advance the upgrade of the innovation ecosystem, industry expert judges spent three months conducting a comprehensive survey. This research assessed Chinese life science service companies based on three dimensions: brand recognition, cost-effectiveness of cooperation, and service satisfaction. The outcome of this meticulous evaluation was the grand unveiling of the "Top 100 Chinese Life Science Service Companies" list at the conference.

Specializing in antibody expression and CRO services for antibody discovery and optimization, Biointron successfully stood out from numerous excellent and highly competitive life science service companies in China. As a result, we have been honored with the award of "Top 100 Chinese Life Science Service Companies of 2023."

Being listed among the top companies represents the industry's recognition of Biointron's capabilities in antibody expression and CRO services for antibody discovery. In the future, Biointron will continue to leverage its innovative and scientific technical advantages. Remaining steadfast in its mission as an "Accelerating Antibody Discovery", we are committed to becoming an outstanding antibody CRO in the global antibody industry, providing one-stop antibody discovery services.

Subscribe to our ブログ

Recent ブログ

The therapeutic efficacy of antibodies is closely related to their ability to recognize and bind specific epitopes on target antigens. Epitopes, or antigenic determinants, are a group of amino acids or other chemical groups that are part of a molecule to which an antibody attaches itself. Epitope characterization can help reveal the mechanism of antibody binding and apply intellectual property (patent) protection for novel antibodies, in addition to designing antibodies with high specificity and minimal cross-reactivity.

Jul 12, 2024
ブログ

Understanding the differences between antibody specificity and selectivity is essential for designing and interpreting antibody-based assays in research for experimental accuracy and data interpretation. Antibody specificity refers to an antibody's ability to recognize and bind to a particular epitope—a unique part of an antigen that elicits an immune response.

Jul 10, 2024
ブログ

Antibody-based assays are essential tools in biomedical research, providing the means to detect, quantify, and visualize specific proteins or antigens within complex biological samples. These assays' efficacy hinges on the antibodies' precise properties. While affinity, avidity, specificity, and selectivity are fundamental to antibody performance, the ultimate impact of these properties is heavily influenced by the experimental context in which the antibody is employed.

Jul 08, 2024
ブログ

Biologics, particularly antibodies, have become indispensable in biomedical research and therapeutic development. Research-use-only (RUO) biologics play a pivotal role in preclinical studies, providing researchers with the necessary tools to explore antibody functions and therapeutic potential in vivo.

Jul 04, 2024
ブログ

お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。